Immuneering (IMRX) Gross Margin (2020 - 2022)
Immuneering (IMRX) posted quarterly Gross Margin of 100.0% for Q4 2022, up 10877.0% year-over-year from N/an in Q4 2021, and up 101.61% quarter-over-quarter from 49.6% in Q3 2022.
Powered by 
Analysis
Immuneering (IMRX) Gross Margin (2020 - 2022) Analysis & Trends
Immuneering's Gross Margin history runs 3 years deep, the most recent figure standing at 100.0% for Q4 2022.
- In Q4 2022, Gross Margin rose 10877.0% year-over-year to 100.0%; the TTM figure through Sep 2023 stood at 100.0% (up 7199.0% YoY), while the FY2022 annual figure was 50.11%, up 555.0% from the prior year.
- Gross Margin for Q4 2022 stood at 100.0%, up from 49.6% in the prior quarter.
- The five-year high for Gross Margin was 100.0% in Q4 2022, with the low at 8.77% in Q4 2021.
- The 3-year median for Gross Margin is 50.55% (2022), against an average of 47.78%.
- The sharpest annual moves came in 2021 and 2022: Gross Margin tumbled 3762 bps in 2021, then surged 10877 bps in 2022.
- Immuneering's Gross Margin stood at 28.85% in 2020, then plunged by 130 bps to 8.77% in 2021, then jumped by 1240 bps to 100.0% in 2022.
- Business Quant data shows IMRX's Gross Margin at 100.0% in Q4 2022, 49.6% in Q3 2022, and 49.23% in Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 35.86% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 89.76% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 76.90% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 84.20% |
| 10 | Immuneering | 313.13 Mn | 313.13 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 100.00% |
| Sep 30, 2022 | 49.60% |
| Jun 30, 2022 | 49.23% |
| Mar 31, 2022 | 50.55% |
| Dec 31, 2021 | -8.77% |
| Sep 30, 2021 | 54.56% |
| Jun 30, 2021 | 51.73% |
| Mar 31, 2021 | 45.31% |
| Dec 31, 2020 | 28.85% |
| Sep 30, 2020 | 53.85% |
| Jun 30, 2020 | 50.70% |